American Journal of Infectious Diseases and Microbiology
ISSN (Print): 2328-4056 ISSN (Online): 2328-4064 Website: http://www.sciepub.com/journal/ajidm Editor-in-chief: Maysaa El Sayed Zaki
Open Access
Journal Browser
Go
American Journal of Infectious Diseases and Microbiology. 2019, 7(2), 57-64
DOI: 10.12691/ajidm-7-2-1
Open AccessArticle

Antibiotics Resistance Profile and Antibacterial Activities of Combretum micranthum and Combretum adenogonium Extracts on Clinical Isolated Vibrio cholera

Bawa Boya1, Théodora A. Ahoyo2, Haziz Sina1, Victorien T. Dougnon3, Christine N'tcha1, Durand Dah-Nouvlessounon1, Delphine B. M. Amoussou2, Charisse Sossa2, Faustine K. Houssa2 and Lamine Baba-Moussa1,

1Laboratoire de Biologie et de Typage Moléculaire en Microbiologie (LBTMM), Département de Biochimie et de Biologie Cellulaire, Faculté des Sciences et Techniques, Université d’Abomey-Calavi, 05 BP 1604 Cotonou, Benin

2Génie de Biologie Humaine, Ecole Polytechnique d’Abomey-Calavi, Benin

3Unité de Recherche en Microbiologie Application et Pharmacologie des substances Naturelles (URMAPha), Université d’Abomey-Calavi, Bénin

Pub. Date: October 25, 2019

Cite this paper:
Bawa Boya, Théodora A. Ahoyo, Haziz Sina, Victorien T. Dougnon, Christine N'tcha, Durand Dah-Nouvlessounon, Delphine B. M. Amoussou, Charisse Sossa, Faustine K. Houssa and Lamine Baba-Moussa. Antibiotics Resistance Profile and Antibacterial Activities of Combretum micranthum and Combretum adenogonium Extracts on Clinical Isolated Vibrio cholera. American Journal of Infectious Diseases and Microbiology. 2019; 7(2):57-64. doi: 10.12691/ajidm-7-2-1

Abstract

Medical care has provided for the use of chemo-selective prophylaxis for doxycycline for patients, health personnel and contacts persons who have no contraindications. Therapeutic failures and the rising costs of treating infections caused by resistant bacteria call for alternative care options. To asses the antibacterial activity of Combretum micranthum and Combretum adenogonium extracts on multi-resistant Vibrio cholerae strains resulting from the 2012-2019 epidemic in Benin. Strains of Vibrio cholerae from the 2012-2019 outbreak and three reference strains (V. cholerae O1 URF-ECMI U67, V. cholerae O1 URF-ECMI U27 and V. cholerae O1 URF-ECMI U14) has been re-isolated on nutrient agar. Strains were identified using standard bacteriology methods (culture, biochemistry, serogroup). The study of antibiotic sensitivity was carried out according to the Kirby-Bauer technique. Strains were sensitive to C. micranthum and C. adenogonium extracts by the agar diffusion method. A total of 84.38% of the Vibrio cholerae strains were recovered. The strains showed resistance (100%) to amoxicillin + clavulanic acid, ceftazidime and oxytetracycline while they are predominantly sensitive to gentamecine (88.46%) and ofloxacin (88.46%). Strains were resistant to Erythromycin (97.56%) and doxycycline (99%). The rate of resistance to Trimethoprim / sulfamethoxazole is 70% of the strains tested. Resistance to doxycycline is 99% while 16.67% of strains tested are resistant to all antibiotics. Strains resistant to antibiotics were sensitive to C. micranthum and C. adenogonium extracts. All are sensitive to the alcoholic extracts of C. adenogonium and 75% are sensitive to the alcoholic extract of C. micranthum. The minimum inhibitory concentrations of the extracts vary between 2.5 mg / ml and 10 mg / ml and the minimum bactericidal concentrations between 2.5 mg/ml and 10 m/ml. The high percentage of resistance to doxycycline and Trimethoprim-sulfamethoxazole insists on reviewing the patient care’s protocol. C. micranthum and C. adenogonium will be an alternative for treating cholera in the community.

Keywords:
Resistance Vibrio cholerae O1 antimicrobial activities C. micranthum C. adenogonium

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Ali, M., Nelson, A.R., Lopez, A.L., and Sack, D, “Updated Global Burden of Cholera in Endemic Countries”. PLoS Neglected Tropical Diseases, 2015; 9(6): e0003832.
 
[2]  Mengel, M.A., Delrieu, I., Heyerdahl, L., and Gessner, B.D, “Cholera outbreaks in Africa”. Current Topics in Microbiology and Immunology. 2014; 379: 117-144.
 
[3]  Yatala, T.N, “Evaluation of the knowledge level of women in the area of health of Kituku on the pathways of contamination of diarrheal diseases”. In Revue University without Borders for an Open Society of the University Production Remote House. 2014, 2: 128-132.
 
[4]  Dao, S., Konaté, I., Alassane, O.A., Sacko, M., Maiga, I., Toure, K. et al.,The epidemics of cholera in Mali from 1995 to 2004. Public Health. 2009, 21: 263-269.
 
[5]  WHO-AFRO. “Regional Framework for the implementation of the global strategy in the fight against cholera 2018-2030”. 2018/AFR/RC68/7.
 
[6]  Makoutode, M., Diallo, F., Mongbo, V., Guevart E., Bazira, L, “The response to the cholera epidemic of 2008 in Cotonou.” Public Health. 2010, 22: 425-435.
 
[7]  Fournier, J.M., “Cholera Medical Encyclopedia surgery.” Infectious Diseases, 8-026-F-10, 1996, 5p.
 
[8]  Adabi, M., Bakhski, B., Goudarzi, H., Zahraei, S.M., Pourshafi, M.R., “Distribution of class 1 integron and sulfamethoxazole trimethoprim constin in Vibrio cholerae isolated from patients in Iran.” Microbiology and Drug Resistance. 2009; 15(3): 179-184.
 
[9]  Manga, N.M., Ndour, C.T., Diop, I.T.S., Dia, N.M., Ka-Sall, R., Diop, B.M., Sow A., Sow P.S.Cholera in Senegal from 2004 to 2006: lessons learned from the successive outbreaks. Medecine Tropicale. 2008; 68(6): 589-92.
 
[10]  Opintan, J.A., Newman, M.J., Nsiah-Poodoh, O.A., Okeke, I.N,Vibrio cholera O1 from Accra, Ghana carrying a class 2 integron and the SXT element”. Journal of Antimicrobial and Chemotherapy. 2008; 62(5):929-933.
 
[11]  Barchan, A., Bakkali, M., Arakrak, A., Laglaoui H.A.S., “Antibacterial effect and anti-biofilm of three species of Mentha: Mentha spicata, Mentha pulegium and Mentha piperita.” Herbal Medicine. 2015, 9.
 
[12]  de Morais, L.G.R., Sales, I.R., Caldas, F.M.R., Jesus, N.Z., De Sousa, F.H., Barbosa-Filho, J.M., et al., “Bioactivities of the genus Combretum (Combretaceae): a review”. Molecules, 2012, 17(8): 142-206.
 
[13]  Eloff JN., Katerere dr., McGaw, Lj. “The biological activity and chemistry of the Southern African Combretaceae”. I Ethnopharmacol, 2008, 119 (3): 686-699.
 
[14]  Nounagnon, S.M., N'tcha, C., Sina, H., Noumavo, A.P., Dah-Nouvlessounon, D., Assogba, M.R.F, et al., Antimicrobial activities of Combretum micranthum extracts on Staphylococcus aureus strains isolated from skin infections and some reference strains. Asian Journal of Plant Science and Research, 2016, 6(4): 40-47.
 
[15]  Ojewole, J.A., “Analgesic and antiinflammatory effects of mollic acid glucoside, has 1 alpha-hydroxycycloartenoid extractive saponin from soft Combretum R. Br. ex G. Don (Combretaceae) leaf. Phototherapy Research, 2008; 22 (1): 30-35.
 
[16]  Touré, A., Xu, X., Michel, T., Bangoura, M., “In vitro Antioxidant and radical scavenging of Guinean kinkeliba leaf (Combretum micranthum G. Don) extracts”. Natural Product Research, 2011, 25 (11): 1025-1036.
 
[17]  Rodier, J., Legube B., Merlet, N., “L’Analyse de l’eau, ” 9ème édition DUNOD, 2009, 749-775.
 
[18]   Sanogo, R., Diallo, D., Diarra, S., Ekoumou, C., and Bougoudogo, A, “Antibacterial activity and anodyne of two traditional recipes used in the treatment of urinary tract infections and cystitis in Mali.” Medical MALI. 2006, 21: 18-24.
 
[19]  N'Guessan K., Kadja B., Zirihi G. N., Traoré D. and Aké-Assi L. “Phytochemical screening of some medicinal plants in Côte d'Ivoire used to Country Krobou (Agboville, Ivory Coast).” Science and Nature, 2009, 6, 1-15.
 
[20]  CA-SFM (Commission de l’Antibiotique de la Société Française de Microbiologie). “Recommandations 2018 du Comité de l’Antibiogramme de la Société Française de Microbiologie”. 2018; 144 p.
 
[21]  Bauer, A.W., Kirby, W.M., Sherris, J.C., Turck, M., “Antibiotic susceptibility testing by a standardized single disk method.” American Journal of Clinical Pathology, 1996, 45, 493-496.
 
[22]  Dah-Nouvlessounon, D., Adoukonou-Sagbadja, H., Diarrassouba, N., Sina, H., Adjonohoun , A., Inoussa M.R., et al. “Phytochemical analysis and biological activities of Cola nitida bark.” Biochemistry Research International. 2015, 1-12.
 
[23]  Mandomando, I., Espasa, M., Vallès, X., Sacarlal, J., Sigaupe, B., Ruiz, I., Alonso, P, “Antimicrobial resistance of Vibrio cholerae O1 serotype ogawa isolated in Manhiça District hospital, southern Mozambique.” Journal of Antimicrobial and Chemotherapy. 2007, 60(3): 662-664.
 
[24]  Shah, R., Parveen, G., Shoukat, M., Khalid , S., Hameed, A., “Isolation, identification, characterization and antibiotic susceptibility of Vibrio cholera during 1998-99. Interantional Journal of Bioscience. 2017, 11(3), 135-147.
 
[25]  Aiyelaagbe, O.O, Hamid, A.A, Fattorusso, E., Taglialatela-Scafati, O., Schröder, H.C., and Müller, W.E., “Cytotoxic activity of crude extracts as well as of pure components from jatropha species, plants used extensively in African Traditional Medicine.” Evidence-Based Complementary and Alternative Medicine, 2011, Article ID 134954, 7 page.
 
[26]  Guevara, J.M, Chumpitaz, J., Valencia, E., “The in vitro action of plants we Vibrio cholerae. Revista de Gastroenterologia del Peru. 1994; 14:27-31.
 
[27]  Thakurta, P., Bhowmik, P., Mukherjee, S., Hajra, T.K., Patra, H.A.S, Bag, P.K., “Antibacterial, antisecretory and antihemorrhagic activity of Azadirachta indica used to treat cholera and diarrhea in India”. Journal of Ethnopharmacology. 2007; 111: 607-12.
 
[28]  Akinsinde, K.A., Olukoya D.K., “Vibriocidal activities of some local herbs”. Journal of Diarrheal Disease Research. 1995; 13: 127-129.